Table 2 Adverse Events and Unadjusted Hazards for Cardiac, Stroke, Mortality and Composite Events Based on Kidney Function Classification
eGFR≥60 | eGFR Increase | eGFR Decline | eGFR < 60 | ||
|---|---|---|---|---|---|
Cardiac | events/at risk; % | 1,088/15,767; 6.9% | 36/276; 13.0% | 143/961; 14.9% | 175/884; 19.8% |
HR (CI) | Reference | 2.10 (1.50, 2.92) | 2.48 (2.08, 2.95) | 3.66 (3.12, 4.30) | |
Stroke | events/at risk; % | 568/15,870; 3.6% | 23/277; 8.3% | 81/970; 8.4% | 114/887; 12.9% |
HR (CI) | Reference | 2.60 (1.71, 3.94) | 2.73 (2.16, 3.44) | 4.68 (3.82, 5.72) | |
Mortality | events/at risk; % | 1,612/15,925; 10.1% | 53/278; 19.1% | 269/972; 27.7% | 367/891; 41.2% |
HR (CI) | Reference | 2.10 (1.60, 2.76) | 3.16 (2.78, 3.60) | 5.27 (4.70, 5.90) | |
Composite | events/at risk; % | 2,584/15,925; 16.2% | 72/278; 25.9% | 356/972; 36.6% | 451/891; 50.6% |
HR (CI) | Reference | 1.81 (1.43, 2.28) | 2.68 (2.40, 2.99) | 4.17 (3.77, 4.61) |